AG
RCUS icon

Algert Global’s Arcus Biosciences RCUS Stock Holding History

Algert Global’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-82,950
Closed -$1.13M – 1288
2025
Q3 		$1.13M Buy
82,950
+5,294
+7% +$55K 0.02% 815
2025
Q2 		$632K Sell
77,656
-191,376
-71% -$1.63M 0.01% 889
2025
Q1 		$2.11M Buy
269,032
+88,910
+49% +$1.03M 0.05% 585
2024
Q4 		$2.68M Buy
180,122
+67,275
+60% +$1.1M 0.06% 508
2024
Q3 		$1.73M Buy
112,847
+36,590
+48% +$577K 0.05% 609
2024
Q2 		$1.16M Buy
76,257
+17,999
+31% +$291K 0.04% 644
2024
Q1 		$1.1M Sell
58,258
-22,790
-28% -$394K 0.04% 590
2023
Q4 		$1.55M Buy
81,048
+9,030
+13% +$144K 0.06% 494
2023
Q3 		$1.29M Buy
72,018
+9,830
+16% +$198K 0.06% 507
2023
Q2 		$1.26M Sell
62,188
-53,901
-46% -$1.03M 0.06% 571
2023
Q1 		$2.12M Buy
116,089
+102,706
+767% +$1.96M 0.1% 325
2022
Q4 		$277K Sell
13,383
-22,910
-63% -$630K 0.02% 945
2022
Q3 		$949K Buy
36,293
+13,603
+60% +$360K 0.06% 570
2022
Q2 		$575K Buy
+22,690
New +$556K 0.04% 707
2020
Q2 		– Sell
-25,378
Closed -$352K – 489
2020
Q1 		$352K Sell
25,378
-76,468
-75% -$951K 0.15% 220
2019
Q4 		$1.03M Buy
101,846
+86,176
+550% +$725K 0.31% 117
2019
Q3 		$143K Buy
+15,670
New +$126K 0.05% 301

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Algert Global's RCUS Position: Q4 2025 in Review

Algert Global sold out of Arcus Biosciences (RCUS) in Q4 2025, closing a stake of 82,950 shares — an estimated $1.13M sold.

Algert Global first reported a position in RCUS in Q3 2019 and held it in 17 quarters. The position peaked at $2.68M in Q4 2024. 209 funds tracked by Wall St. Rank hold RCUS as of Q4 2025.

  • Algert Global reported no remaining Arcus Biosciences position as of Q4 2025 after selling out during the quarter.
  • Algert Global sold 82,950 Arcus Biosciences shares in Q4 2025, an estimated $1.13M.
  • Algert Global first reported a position in Arcus Biosciences in Q3 2019 and held it in 17 quarters.
  • Algert Global's Arcus Biosciences position peaked at $2.68M in Q4 2024.
  • 209 funds tracked by Wall St. Rank held Arcus Biosciences as of Q4 2025.

Based on Algert Global's 13F filing for Q4 2025, filed 17 Feb 2026.